Neuro-oncology
Conference Coverage
First target doesn’t affect survival in NSCLC with brain metastases
Patient outcomes didn’t hinge on whether oncologists treated the brain or lung first.
Commentary
Local therapies show promise for metastatic lung cancer
Local therapy for colorectal cancer with limited liver-only metastases is now established as a path to potentially excellent long-term survival....
Latest News
A single pediatric CT scan raises brain cancer risk
"CT examinations should only be used when necessary, and if they are used, the lowest achievable dose should be applied."
From the Journals
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.
Feature
Glioblastoma spreading strategies discovered
The more-or-less specific interaction between the nerve cells and the tumor cells also offers starting points for therapies, from our point of...
Conference Coverage
A farewell to arms? Drug approvals based on single-arm trials can be flawed
Objective responses, not time-dependent survival outcomes, should be endpoints for single-arm trials, with results only used for conditional...
Conference Coverage
Time to cancer diagnoses in U.S. averages 5 months
Diagnosis time varied significantly across tumor types, as well as within the same tumor type.
From the Journals
Quality of life benefit exaggerated in some cancer studies
From the Journals
Cancer may increase risk of type 2 diabetes
Study demonstrates elevated risk of developing diabetes for people with lung, pancreatic, breast, brain, urinary tract, or uterine cancers
From the Journals
Good chemo vs. bad chemo: When too much is a bad thing
Study questions the use of inpatient chemotherapy pointing to negative outcomes and high mortality among some patients.
Conference Coverage
Collagen ‘tile’ delivers postsurgical radiation in glioblastoma
If replicated in larger trials, GT therapy “could define a new standard of care, and there would really be no reason why patients shouldn’t get...